×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4010579
Return to Previous Page
4010579

Availability: In stock

Bombesin trifluoroacetate salt
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ trifluoroacetate salt

4010579

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4010579.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 210.00
CHF 195.30 (7%)
4010579.0025 25 mg Ships within 3-5 business days  
CHF 840.00
CHF 781.20 (7%)

Details

A tetradecapeptide isolated from amphibian skin, which is biologically active in both the central nervous system and gastrointestinal tract. It was also shown that bombesin suppresses feeding in rats. Bombesin-like peptides have been biochemically characterized in rat brain.
Catalog Number H-2155
APC Number 16-7-10
One Letter Code pEQRLGNQWAVGHLM-NH₂
Molecular Formula C₇₁H₁₁₀N₂₄O₁₈S
Relative Molecular Mass 1619.87
CAS Registry Number 31362-50-2
Source Synthetic
Storage Conditions -20 ± 5 °C
Keywords Anorexigenic amphibian peptide
Application Cancer Research
Gastrointestinal Research
Obesity Research
Links / Documents:
Brochures:

Bachem product citations

C.Morgat et al., Med. Chem. Comm., 7, 1217 (2016)
B.Svendsen et al., J. Endocrinol., 228, 39 (2016)
I.E.Valverde et al., J. Med. Chem., 59, 3867 (2016)
I.E.Valverde et al., J. Med. Chem., 58, 7475 (2015)
B.L.Panaro et al., Cell Metab., 20, 1018 (2014)
J.M.Ho et al., Endocrinology, 155, 2845 (2014)
J.R.Reeve, Jr. et al., Peptides, 59, 1 (2014)
I.E.Valverde et al., Angew. Chem. Int. Ed. Engl., 52, 8957 (2013)
C.A.Kluba et al., Org. Biomol. Chem., 10, 7594 (2012)
F.Verrier et al., Nat. Chem. Biol., 7, 909 (2011)
P.W.Chen and G.S.Kroog, Cell Adh. Migr., 4, 527 (2010)
F.M.Sinner et al., J. Chromatogr. A., 1191, 274 (2008)
M.Schumann et al., Biochem. Pharmacol., 75, 1170 (2008)
C.H.Kubisch and C.D.Logsdon, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G1804 (2007)
E.Garcia Garayoa et al., Nucl. Med. Biol., 34, 17 (2007)
L.N.Axelsen et al., J. Mol. Cell. Cardiol., 40, 790 (2006)
T.Nakagawa et al., Biochem. Pharmacol., 69, 579 (2005)
M.D.Sans et al., Biochem. Biophys. Res. Commun., 319, 144 (2004)
S.A.Mantey et al., J. Pharmacol. Exp. Ther., 310, 1161 (2004)
Y.Bangale et al., FASEB J., 17, 628 (2003)
M.Farquhar et al., Chem. Biol., 9, 63 (2002)
R.La Bella et al., Nucl. Med. Biol., 29, 553 (2002)
R.La Bella et al., Bioconjug. Chem., 13, 599 (2002)
D.H.Presky and A.Schonbrunn, J. Cell Biol., 102, 878 (1986)

Product citations

G.Bertaccini et al., Br. J. Pharmacol., 52, 219 (1974)
A.Anastasi et al., Experientia, 27, 166 (1971)

4010579

Enzyme Substrates Inhibitors
Neurolysin